Ny Sin

3.0k citations
20 papers · 2.0k indexed · 2 hit papers · h-index 14

Ny Sin

19 papers receiving 1.9k citations

Hit Papers

Epoxomicin, a potent and selective proteasome inhibitor, ...8031997202620062016250500750

Peers

Ny Sin
Comparison fields: 5 of 101
  • Oncology 739
  • Molecular Biology 1.5k
  • Cancer Research 219
  • Cell Biology 206
  • Hematology 119
Replace Soongyu Choi with:
Soongyu Choi United States
Stefania Di Marco Italy
Hong Wu China
Frank J. Schoenen United States
Brian S. Chang United States
David M. Duda United States
Miklós Békés United States
V M Garsky United States
David P. Nusinow United States
Peter D. Mace New Zealand
Ny Sin relative to Soongyu Choi United States Soongyu Choi's profile →
Citations per field
00.5×4.7×
Soongyu Choi · 1×
Citations per year

Countries citing papers authored by Ny Sin

Since Specialization
Citations

This map shows the geographic impact of Ny Sin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ny Sin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ny Sin more than expected).

Fields of papers citing papers by Ny Sin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ny Sin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ny Sin. The network helps show where Ny Sin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ny Sin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ny Sin Line = papers co-authored together Ny Sin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20240
2 20211
3 201818
4 201626
5 20104
6 200936
7 200914
8 200458
9 1999164
10 1999103
11
Eponemycin exerts its antitumor effect through the inhibition of proteasome function.
1999132
12
Epoxomicin, a potent and selective proteasome inhibitor, exhibitsin vivoantiinflammatory activitybreakdown →
1999803
13 199850
14 199831
15 19972
16
The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2breakdown →
1997530
17 199615
18 199316
19 19904
20 19893

About Ny Sin

Ny Sin is a scholar working on Virology, Biophysics, Cancer Research, Hepatology and Organic Chemistry, having authored 20 papers that have together received 2.0k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (6 papers), Ubiquitin and proteasome pathways (4 papers), HIV Research and Treatment (3 papers), HIV/AIDS drug development and treatment (3 papers), Carbohydrate Chemistry and Synthesis (3 papers), Respiratory viral infections research (2 papers), Virology and Viral Diseases (2 papers) and Electron Spin Resonance Studies (2 papers). The work is most often cited by research in Oncology (739 citations), Molecular Biology (1.5k citations), Cancer Research (219 citations), Cell Biology (206 citations) and Hematology (119 citations). Ny Sin has collaborated with scholars based in United States and Germany. Frequent co-authors include Craig M. Crews, Lihao Meng, Benjamin H. Kwok, Mikael Elofsson, Royce Mohan, William G. Bornmann, James Wen, Kyung Bo Kim, Lin Meng and Jayhyuk Myung. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Tetrahedron Letters, Proceedings of the National Academy of Sciences, Magnetic Resonance in Chemistry and Bioorganic & Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026